MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
"Triple Helix" Innovation Model
4. Triple Helix _ Capture Strategies
Triple Helix: Reports, Publications & Metrics
Triple Helix: Regional Innovation Clusters (RIC)s
Intermediaries: Triple Helix Regional Innovation Clusters (RIC)s
RICS (Regional Innovation Clusters) - Medical, Life Sciences & Emerging Technology Hotspots
*Industry: Northern California & Silicon Valley
Arresto Biosciences Inc.
Parents
*Architects: Cancer & Oncology Companies _Pharmaceuticals & Biotechnology
*Industry: Northern California & Silicon Valley
*Industry: Palo Alto, California
Companies: Acquired_(M&A)
Finance & Acquisitions: Gilead
Children
2010: Gilead to acquire Arresto for $225M (2010)
Arresto develops medicines that target enzymes involved in the synthesis of the extracellular matrix, which appear to play a role in the etiology of a variety of fibrotic diseases and cancer.
Development-stage biotechnology company focused on medicines to treat fibrotic diseases and cancer.
Palo Alto, California
The company is backed by Menlo Park-based Kleiner Perkins Caufield & Byers, Cambridge, Mass.-based HealthCare Ventures, Danville-based Northgate Capital, Palo Alto-based DAG Ventures and Abbott Biotech Ventures.
The company’s lead product is AB0024, a humanized monoclonal antibody. Read more: Gilead to acquire Arresto for $225M | Silicon Valley / San Jose Business Journal